JP2022533422A5 - - Google Patents
Info
- Publication number
- JP2022533422A5 JP2022533422A5 JP2021569155A JP2021569155A JP2022533422A5 JP 2022533422 A5 JP2022533422 A5 JP 2022533422A5 JP 2021569155 A JP2021569155 A JP 2021569155A JP 2021569155 A JP2021569155 A JP 2021569155A JP 2022533422 A5 JP2022533422 A5 JP 2022533422A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- disease
- use according
- alzheimer
- amyloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175810.1 | 2019-05-21 | ||
| EP19175810 | 2019-05-21 | ||
| EP19185593.1 | 2019-07-10 | ||
| EP19185593 | 2019-07-10 | ||
| EP20171549 | 2020-04-27 | ||
| EP20171549.7 | 2020-04-27 | ||
| EP20172205 | 2020-04-29 | ||
| EP20172205.5 | 2020-04-29 | ||
| PCT/EP2020/064172 WO2020234405A1 (en) | 2019-05-21 | 2020-05-20 | Anti-abeta vaccine therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533422A JP2022533422A (ja) | 2022-07-22 |
| JP2022533422A5 true JP2022533422A5 (enExample) | 2023-05-29 |
| JP7701734B2 JP7701734B2 (ja) | 2025-07-02 |
Family
ID=70740677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569155A Active JP7701734B2 (ja) | 2019-05-21 | 2020-05-20 | 抗ａベータワクチン療法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220226447A1 (enExample) |
| EP (1) | EP3972633A1 (enExample) |
| JP (1) | JP7701734B2 (enExample) |
| KR (1) | KR20220010552A (enExample) |
| CN (1) | CN113853214A (enExample) |
| AU (1) | AU2020277682A1 (enExample) |
| BR (1) | BR112021023209A2 (enExample) |
| CA (1) | CA3138145A1 (enExample) |
| CL (1) | CL2021003051A1 (enExample) |
| IL (1) | IL288252A (enExample) |
| MX (1) | MX2021014102A (enExample) |
| MY (1) | MY210394A (enExample) |
| SG (1) | SG11202112329RA (enExample) |
| TW (1) | TW202110425A (enExample) |
| WO (1) | WO2020234405A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021260193A1 (en) * | 2020-06-25 | 2021-12-30 | Medimmune Limited | Prevention of axonal damage using antibody binding to amyloid beta 1-42 |
| KR20250137159A (ko) * | 2023-01-26 | 2025-09-17 | 에이씨 이뮨 에스에이 | 항-a베타 백신 요법 |
| WO2025109524A1 (en) * | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| KR101152557B1 (ko) * | 2005-12-12 | 2012-09-07 | 에이씨 이뮨 에스.에이. | 치료 백신 |
| HUE055739T2 (hu) * | 2009-03-18 | 2021-12-28 | Ac Immune Sa | Eljárás terápiás alkalmazásra |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| JP6027011B2 (ja) | 2010-10-26 | 2016-11-16 | エーシー イミューン ソシエテ アノニム | 疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物 |
| CA2811188C (en) * | 2011-09-23 | 2020-04-28 | Andrea Pfeifer | Vaccine therapy |
| AU2019253193B2 (en) | 2018-04-10 | 2026-02-05 | Ac Immune Sa | Anti-abeta therapeutic vaccines |
-
2020
- 2020-05-20 SG SG11202112329RA patent/SG11202112329RA/en unknown
- 2020-05-20 EP EP20726473.0A patent/EP3972633A1/en active Pending
- 2020-05-20 KR KR1020217041697A patent/KR20220010552A/ko active Pending
- 2020-05-20 TW TW109116790A patent/TW202110425A/zh unknown
- 2020-05-20 MY MYPI2021006840A patent/MY210394A/en unknown
- 2020-05-20 JP JP2021569155A patent/JP7701734B2/ja active Active
- 2020-05-20 CN CN202080035690.8A patent/CN113853214A/zh active Pending
- 2020-05-20 CA CA3138145A patent/CA3138145A1/en active Pending
- 2020-05-20 AU AU2020277682A patent/AU2020277682A1/en active Pending
- 2020-05-20 MX MX2021014102A patent/MX2021014102A/es unknown
- 2020-05-20 BR BR112021023209A patent/BR112021023209A2/pt unknown
- 2020-05-20 WO PCT/EP2020/064172 patent/WO2020234405A1/en not_active Ceased
- 2020-05-20 US US17/612,921 patent/US20220226447A1/en active Pending
-
2021
- 2021-11-18 CL CL2021003051A patent/CL2021003051A1/es unknown
- 2021-11-21 IL IL288252A patent/IL288252A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533422A5 (enExample) | ||
| EP2297196B1 (en) | Vaccine against amyloid folding intermediate | |
| KR20020073341A (ko) | 알츠하이머 및 아밀로이드 관련 질병의 예방 및 치료용 백신 | |
| KR102869640B1 (ko) | 항-aveta 치료적 백신 | |
| JP2022529529A5 (enExample) | ||
| JP2012522754A5 (enExample) | ||
| HUP0301043A2 (hu) | Vakcina | |
| JP2024178161A (ja) | リン酸化タウペプチドワクチンの安全な投与の方法 | |
| JP2003532618A5 (enExample) | ||
| JP2025084745A5 (enExample) | ||
| US4624946A (en) | Treatment of involutional brain syndromes and mental decay | |
| CL2021003051A1 (es) | Terapia de vacuna anti-abeta. | |
| JP2025506472A5 (enExample) | ||
| JP2014531455A5 (enExample) | ||
| US20250152684A1 (en) | Anti-Alpha-Synuclein Therapeutic Vaccines | |
| RU2025121137A (ru) | Терапия на основе вакцины против бета-амилоида | |
| US8906382B2 (en) | Method for treating amyloid disease | |
| EP1764369A1 (de) | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants | |
| JP2024538615A5 (enExample) | ||
| JP2024532787A5 (enExample) | ||
| CN104892474A (zh) | 用于治疗脱髓鞘性周围神经病的氨基醇衍生物 | |
| WO2006097416A1 (en) | Compounds for use in the prevention and treatment of alzheimer's disease | |
| CN118613496A (zh) | 安全施用Tau磷酸肽缀合物的方法 | |
| EP1902727A1 (de) | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants | |
| EA202193183A1 (ru) | Терапия с помощью вакцины против бета-амилоида |